Your request to link to rcsb for BDBM50136579

---

• 5E2P: factor xia in complex with the inhibitor n-[(1s)-1-benzyl-2-[2-[5- chloro-2-(tetrazol-1-yl)phenyl]ethylamino]-2-oxo-ethyl]-4-hydroxy-2- oxo-1h-quinoline-6-carboxamide (10.1016/J.BMCL.2015.11.089 )
• 4CRB: creating novel f1 inhibitors through fragment based lead generation and structure aided drug design (10.1371/JOURNAL.PONE.0113705 )